中国药师对仿制药认知的调查研究

doi:10.5246/jcps.2020.05.034

中国药学(英文版) ›› 2020, Vol. 29 ›› Issue (5): 364-368.DOI: 10.5246/jcps.2020.05.034

• 【药事管理与临床药学专栏】 • 上一篇下一篇

中国药师对仿制药认知的调查研究

聂玉瑶¹, 王贺¹, 周林光², 史录文¹, 江滨^1*

1. 北京大学医学部药学院药事管理与临床药学系, 北京 100191
2. 北京大学国际医院药剂科, 北京 102206

收稿日期:2019-12-21 修回日期:2020-01-11 出版日期:2020-05-31 发布日期:2020-03-15
通讯作者: Tel.: +86-13601100121, E-mail: binjiangpku@126.com

Pharmacists’ perceptions of generic drugs in China

Yuyao Nie¹, He Wang¹, Linguang Zhou², Luwen Shi¹, Bin Jiang^1*

1. Department of Administrative and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University Health Science Center, Beijing 100191, China
2. Department of Pharmacy, International Hospital Peking University, Beijing 102206, China

Received:2019-12-21 Revised:2020-01-11 Online:2020-05-31 Published:2020-03-15
Contact: Tel.: +86-13601100121, E-mail: binjiangpku@126.com

摘要/Abstract

摘要：

2018年8月至12月, 采用在微信群中发放电子问卷的便于抽样的方法, 对中国药师对仿制药的认知情况进行了横断面研究。对577份药师问卷进行分析。相当一部分药师对仿制药持否定认知, 比如认为仿制药与品牌药相比疗效更差、更不安全, 而且更容易产生副作用。针对仿制药的误解的教育活动可能是必要的。

关键词: 仿制药, 仿制药替代, 认知, 药师

Abstract:

Perceptions of Chinese pharmacists towards generic drugs were evaluated by a cross-sectional study from Aug. 2018 to Dec. 2018. Online survey tool Sojump was adopted to release the questionnaires using convenience sampling. A total of 577 questionnaires by pharmacists were analyzed. A meaningful proportion of pharmacists expressed negative perceptions of generic drugs, such as perceiving generics as less effective, less safe and more likely to cause side effects compared to their branded equivalents. Educational campaigns that focus on misperceptions of generic drugs may be necessary.

Key words: Generic drug, Generic substitution, Perception, Pharmacist

中图分类号:

R951

Supporting:

聂玉瑶, 王贺, 周林光, 史录文, 江滨. 中国药师对仿制药认知的调查研究[J]. 中国药学(英文版), 2020, 29(5): 364-368.

Yuyao Nie, He Wang, Linguang Zhou, Luwen Shi, Bin Jiang. Pharmacists’ perceptions of generic drugs in China[J]. Journal of Chinese Pharmaceutical Sciences, 2020, 29(5): 364-368.

参考文献

[1] Dylst, P.; Vulto, A.; Simoens, S. Demand-side policies to encourage the use of generic medicines: an overview. Expert Rev. Pharmacoecon. Outcomes Res. 2013, 13, 59-72.

[2] Hassali, M.A.; Alrasheedy, A.A.; McLachlan, A.; Nguyen, T.A.; Al-Tamimi, S.K.; Ibrahim, M.I.; Aljadhey, H. The experiences of implementing generic medicine policy in eight countries: a review and recommendations for a successful promotion of generic medicine use. Saudi Pharm. J. 2014, 22, 491-503.

[3] Colgan, S.; Faasse, K.; Martin, L.R.; Stephens, M.H.; Grey, A.; Petrie, K.J. Perceptions of generic medication in the general population, doctors and pharmacists: a systematic review. BMJ Open. 2015, 5, 12.

[4] Dunne, S.S.; Dunne, C.P. What do people really think of generic medicines? A systematic review and critical appraisal of literature on stakeholder perceptions of generic drugs. BMC Med. 2015, 13, 173.

[5] Toverud, E.L.; Hartmann, K.; Håkonsen, H. A systematic review of physicians’ and pharmacists’ perspectives on generic drug use: what are the global challenges? Appl. Health Econ. Health Policy. 2015, 13 Suppl 1, S35-S45.

[6] Gu, X.C.; MEN, P.; ZHAI, S.D. Questionnaire survey on pharmacists’ attitude to safety and efficacy of original patented drug and generic drug of metformin. Chin. J. Hosp. Pharm. 2017, 13, 4.

[7] Babar, Z.U.; Grover, P.; Stewart, J.; Hogg, M.; Short, L.; Seo, H.G.; Rew, A. Evaluating pharmacists’ views, knowledge, and perception regarding generic medicines in New Zealand. Res. Social Adm. Pharm. 2011, 7, 294-305.

[8] Maly, J.; Dosedel, M.; Kubena, A.; Vlcek, J. Analysis of pharmacists' opinions, attitudes and experiences with generic drugs and generic substitution in the Czech Republic. Acta Pol. Pharm. 2013, 70, 923-931.

[9] Chong, C.P.; Hassali, M.A.; Bahari, M.B.; Shafie, A.A. Exploring community pharmacists’ views on generic medicines: a nationwide study from Malaysia. Int. J. Clin. Pharm. 2011, 33, 124-131.

[10] Chong, C.P.; March, G.; Clark, A.; Gilbert, A.; Hassali, M.A.; Bahari, M.B. A nationwide study on generic medicines substitution practices of Australian community pharmacists and patient acceptance. Health Policy. 2011, 99, 139-148.

[11] Allenet, B.; Barry, H. Opinion and behaviour of pharmacists towards the substitution of branded drugs by generic drugs: survey of 1,000 French community pharmacists. Pharm. World Sci. 2003, 25, 197-202.

[12] Zhou, R.J.; Jiang, B. Effects of drug purchasing under joint price caps policy in Fujian Province, China. J. Chin. Pharm. Sci. 2020, 29, 139-152.

[1]	刘文夏, 马俊, 杨照, 江滨. 中国仿制药替代影响因素分析——基于"4 + 7"带量采购精神科用药患者角度[J]. 中国药学(英文版), 2023, 32(4): 317-321.
[2]	袁叶, 于博, 杨珍珍, 董维冲, 杨秀岭. 达格列净在血容量不足患者中的药学监护及文献分析[J]. 中国药学(英文版), 2022, 31(9): 718-722.
[3]	杨东升, 魏宁漪, 牛剑钊, 许鸣镝. 治疗等效性评价代码介绍及其对我国仿制药参比制剂选择的影响[J]. 中国药学(英文版), 2022, 31(8): 646-651.
[4]	谢文军, 肖浩然, 王新童, 黄宗泽, 卞希玲, 王克威, 孙崎. 基于Sonogashira偶联反应得到的新型α7尼古丁乙酰胆碱受体正向变构调节剂[J]. 中国药学(英文版), 2022, 31(5): 374-381.
[5]	涂颖秋, 胥甜甜, 彭洪薇, 陈长仁, 赖鑫, 万青, 潘德城, 张洁. 药师主导的肠外营养处方审核策略的分析与改进[J]. 中国药学(英文版), 2022, 31(2): 142-152.
[6]	周毅, 吴星烨, 李娟, 程伟, 李小松, 沈依帆, 张军. 药师在胃肠间质瘤多学科诊疗团队中的作用[J]. 中国药学(英文版), 2021, 30(7): 598-605.
[7]	谢英, 战寒秋, 朱晓虹, 李源, 田如意, 张静, 陈姗姗, 赵艳玲. 恩替卡韦仿制药与原研药治疗慢性乙型肝炎的疗效及依从性的多中心队列研究[J]. 中国药学(英文版), 2021, 30(12): 986-993.
[8]	杨东升, 马玲云, 牛剑钊, 许鸣镝. 美国授权仿制药应用简介[J]. 中国药学(英文版), 2019, 28(6): 439-445.
[9]	杨东升, 马玲云, 牛剑钊, 许鸣镝. 美国国家药品编码应用简介[J]. 中国药学(英文版), 2019, 28(3): 203-208.
[10]	严妍, 李玲, 李蕊, 于文君, 韩毅, 马玉奎, 李妍. 二甲双胍原研制剂格华止?与一种仿制制剂在大鼠模型中药代动力学和药效学比较[J]. 中国药学(英文版), 2019, 28(2): 134-142.
[11]	冯书云, 郭锦辉, 卢乙众. 新医改形势下药学服务与药师价值的探索[J]. 中国药学(英文版), 2018, 27(9): 630-636.
[12]	牛剑钊, 杨东升, 许鸣镝. 欧盟仿制药参比制剂检索与确认简介[J]. 中国药学(英文版), 2018, 27(11): 805-812.
[13]	王利群, 谢晓慧, 周瑞瑞. 我国大陆期刊哮喘药学服务随机对照研究的质量评价[J]. 中国药学(英文版), 2017, 26(3): 212-221.
[14]	赵琪, 徐晓媛, 张洁菡. 我国药师胜任力模型构建研究[J]. 中国药学(英文版), 2016, 25(11): 846-854.
[15]	朱愿超, 胡永芳, 杨莉萍, 胡欣. 临床药师干预对甲状腺手术围术期预防应用抗菌药物的影响[J]. 中国药学(英文版), 2015, 24(9): 617-624.

中国药师对仿制药认知的调查研究

Pharmacists’ perceptions of generic drugs in China

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价